Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Jul;37(7):501–509. doi: 10.1136/jmg.37.7.501

Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon

M Fruhwald 1, M O'Dorisio 1, L Rush 1, J Reiter 1, D Smiraglia 1, G Wenger 1, J Costello 1, P White 1, R Krahe 1, G Brodeur 1, C Plass 1
PMCID: PMC1734623  PMID: 10882752

Abstract

OBJECTIVES—The pathological entity of primitive neuroectodermal tumour/medulloblastoma (PNET/MB) comprises a very heterogeneous group of neoplasms on a clinical as well as on a molecular level. We evaluated the importance of DNA amplification in medulloblastomas and other primitive neuroectodermal tumours (PNETs) of the CNS.
METHOD—Restriction landmark genomic scanning (RLGS), a method that allows the detection of low level amplification, was used. RLGS provides direct access to DNA sequences circumventing positional cloning efforts. Furthermore, we analysed several samples by CGH.
DESIGN—Twenty primary medulloblastomas, five supratentorial PNETs, and five medulloblastoma cell lines were studied.
RESULTS—Although our analysis confirms that gene amplification is generally a rare event in childhood PNET/MB, we found a total of 17 DNA fragments that were amplified in seven different tumours. Cloning and sequencing of several of these fragments confirmed the previous finding of MYC amplification in the cell line D341 Med and identified novel DNA sequences amplified in PNET/MB. We describe for the first time amplification of the novel gene, NAG, in a subset of PNET/MB. Despite genomic amplification, NAG was not overexpressed in the tumours studied. We have determined that NAG maps less than 50 kb 5' of DDX1 and approximately 400 kb telomeric of MYCN on chromosome 2p24.
CONCLUSION—We found a similar but slightly higher frequency of amplification than previously reported. We present several DNA fragments that may belong to the CpG islands of novel genes amplified in a small subset of PNET/MB. As an example we describe for the first time the amplification of NAG in the MYCN amplicon in PNET/MB.


Keywords: medulloblastoma; PNET; NAG amplification; RLGS

Full Text

The Full Text of this article is available as a PDF (193.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama K., Kanda N., Yamada M., Tadokoro K., Matsunaga T., Nishi Y. Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomas. Nucleic Acids Res. 1994 Jan 25;22(2):187–193. doi: 10.1093/nar/22.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Biegel J. A., Janss A. J., Raffel C., Sutton L., Rorke L. B., Harper J. M., Phillips P. C. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system. Clin Cancer Res. 1997 Mar;3(3):473–478. [PubMed] [Google Scholar]
  3. Bigner S. H., Friedman H. S., Vogelstein B., Oakes W. J., Bigner D. D. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res. 1990 Apr 15;50(8):2347–2350. [PubMed] [Google Scholar]
  4. Bruggers C. S., Tai K. F., Murdock T., Sivak L., Le K., Perkins S. L., Coffin C. M., Carroll W. L. Expression of the c-Myc protein in childhood medulloblastoma. J Pediatr Hematol Oncol. 1998 Jan-Feb;20(1):18–25. doi: 10.1097/00043426-199801000-00003. [DOI] [PubMed] [Google Scholar]
  5. Burnett M. E., White E. C., Sih S., von Haken M. S., Cogen P. H. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet. 1997 Aug;97(1):25–31. doi: 10.1016/s0165-4608(96)00319-6. [DOI] [PubMed] [Google Scholar]
  6. Caputy A. J., McCullough D. C., Manz H. J., Patterson K., Hammock M. K. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation. J Neurosurg. 1987 Jan;66(1):80–87. doi: 10.3171/jns.1987.66.1.0080. [DOI] [PubMed] [Google Scholar]
  7. Costello J. F., Plass C., Arap W., Chapman V. M., Held W. A., Berger M. S., Su Huang H. J., Cavenee W. K. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 1997 Apr 1;57(7):1250–1254. [PubMed] [Google Scholar]
  8. Curtis L. J., Li Y., Gerbault-Seureau M., Kuick R., Dutrillaux A. M., Goubin G., Fawcett J., Cram S., Dutrillaux B., Hanash S. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics. 1998 Oct 1;53(1):42–55. doi: 10.1006/geno.1998.5405. [DOI] [PubMed] [Google Scholar]
  9. Deloukas P., Schuler G. D., Gyapay G., Beasley E. M., Soderlund C., Rodriguez-Tomé P., Hui L., Matise T. C., McKusick K. B., Beckmann J. S. A physical map of 30,000 human genes. Science. 1998 Oct 23;282(5389):744–746. doi: 10.1126/science.282.5389.744. [DOI] [PubMed] [Google Scholar]
  10. Duffner P. K., Cohen M. E., Myers M. H., Heise H. W. Survival of children with brain tumors: SEER Program, 1973-1980. Neurology. 1986 May;36(5):597–601. doi: 10.1212/wnl.36.5.597. [DOI] [PubMed] [Google Scholar]
  11. Fuller G. N., Bigner S. H. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res. 1992 May;276(3):299–306. doi: 10.1016/0165-1110(92)90016-3. [DOI] [PubMed] [Google Scholar]
  12. Garson J. A., Pemberton L. F., Sheppard P. W., Varndell I. M., Coakham H. B., Kemshead J. T. N-myc gene expression and oncoprotein characterisation in medulloblastoma. Br J Cancer. 1989 Jun;59(6):889–894. doi: 10.1038/bjc.1989.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. George R. E., Kenyon R. M., McGuckin A. G., Malcolm A. J., Pearson A. D., Lunec J. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. Oncogene. 1996 Apr 4;12(7):1583–1587. [PubMed] [Google Scholar]
  14. Gyapay G., Schmitt K., Fizames C., Jones H., Vega-Czarny N., Spillett D., Muselet D., Prud'homme J. F., Dib C., Auffray C. A radiation hybrid map of the human genome. Hum Mol Genet. 1996 Mar;5(3):339–346. doi: 10.1093/hmg/5.3.339. [DOI] [PubMed] [Google Scholar]
  15. Harisiadis L., Chang C. H. Medulloblastoma in children: a correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys. 1977 Sep-Oct;2(9-10):833–841. doi: 10.1016/0360-3016(77)90181-x. [DOI] [PubMed] [Google Scholar]
  16. Hirotsune S., Hatada I., Komatsubara H., Nagai H., Kuma K., Kobayakawa K., Kawara T., Nakagawara A., Fujii K., Mukai T. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res. 1992 Jul 1;52(13):3642–3647. [PubMed] [Google Scholar]
  17. Hudson T. J., Stein L. D., Gerety S. S., Ma J., Castle A. B., Silva J., Slonim D. K., Baptista R., Kruglyak L., Xu S. H. An STS-based map of the human genome. Science. 1995 Dec 22;270(5244):1945–1954. doi: 10.1126/science.270.5244.1945. [DOI] [PubMed] [Google Scholar]
  18. Jenkin D., Goddard K., Armstrong D., Becker L., Berry M., Chan H., Doherty M., Greenberg M., Hendrick B., Hoffman H. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys. 1990 Aug;19(2):265–274. doi: 10.1016/0360-3016(90)90533-p. [DOI] [PubMed] [Google Scholar]
  19. Kallioniemi A., Kallioniemi O. P., Sudar D., Rutovitz D., Gray J. W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992 Oct 30;258(5083):818–821. doi: 10.1126/science.1359641. [DOI] [PubMed] [Google Scholar]
  20. Klein H. L. A radical solution to death. Nat Genet. 2000 Jun;25(2):132–134. doi: 10.1038/75957. [DOI] [PubMed] [Google Scholar]
  21. Kuroda H., White P. S., Sulman E. P., Manohar C. F., Reiter J. L., Cohn S. L., Brodeur G. M. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN. Oncogene. 1996 Oct 3;13(7):1561–1565. [PubMed] [Google Scholar]
  22. Maris J. M., Matthay K. K. Molecular biology of neuroblastoma. J Clin Oncol. 1999 Jul;17(7):2264–2279. doi: 10.1200/JCO.1999.17.7.2264. [DOI] [PubMed] [Google Scholar]
  23. Miano J. M., Krahe R., Garcia E., Elliott J. M., Olson E. N. Expression, genomic structure and high resolution mapping to 19p13.2 of the human smooth muscle cell calponin gene. Gene. 1997 Sep 15;197(1-2):215–224. doi: 10.1016/s0378-1119(97)00265-5. [DOI] [PubMed] [Google Scholar]
  24. Miwa W., Yashima K., Sekine T., Sekiya T. Demethylation of a repetitive DNA sequence in human cancers. Electrophoresis. 1995 Feb;16(2):227–232. doi: 10.1002/elps.1150160138. [DOI] [PubMed] [Google Scholar]
  25. Nisen P. D., Zimmerman K. A., Cotter S. V., Gilbert F., Alt F. W. Enhanced expression of the N-myc gene in Wilms' tumors. Cancer Res. 1986 Dec;46(12 Pt 1):6217–6222. [PubMed] [Google Scholar]
  26. Pietsch T., Scharmann T., Fonatsch C., Schmidt D., Ockler R., Freihoff D., Albrecht S., Wiestler O. D., Zeltzer P., Riehm H. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1994 Jun 15;54(12):3278–3287. [PubMed] [Google Scholar]
  27. Plass C., Shibata H., Kalcheva I., Mullins L., Kotelevtseva N., Mullins J., Kato R., Sasaki H., Hirotsune S., Okazaki Y. Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet. 1996 Sep;14(1):106–109. doi: 10.1038/ng0996-106. [DOI] [PubMed] [Google Scholar]
  28. Plass C., Weichenhan D., Catanese J., Costello J. F., Yu F., Yu L., Smiraglia D., Cavenee W. K., Caligiuri M. A., deJong P. An arrayed human not I-EcoRV boundary library as a tool for RLGS spot analysis. DNA Res. 1997 Jun 30;4(3):253–255. doi: 10.1093/dnares/4.3.253. [DOI] [PubMed] [Google Scholar]
  29. Plass C., Yu F., Yu L., Strout M. P., El-Rifai W., Elonen E., Knuutila S., Marcucci G., Young D. C., Held W. A. Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene. Oncogene. 1999 May 20;18(20):3159–3165. doi: 10.1038/sj.onc.1202651. [DOI] [PubMed] [Google Scholar]
  30. Reardon D. A., Michalkiewicz E., Boyett J. M., Sublett J. E., Entrekin R. E., Ragsdale S. T., Valentine M. B., Behm F. G., Li H., Heideman R. L. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res. 1997 Sep 15;57(18):4042–4047. [PubMed] [Google Scholar]
  31. Reiter J. L., Brodeur G. M. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas. Genomics. 1996 Feb 15;32(1):97–103. doi: 10.1006/geno.1996.0081. [DOI] [PubMed] [Google Scholar]
  32. Reiter J. L., Brodeur G. M. MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas. Genes Chromosomes Cancer. 1998 Oct;23(2):134–140. doi: 10.1002/(sici)1098-2264(199810)23:2<134::aid-gcc6>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  33. Rouah E., Wilson D. R., Armstrong D. L., Darlington G. J. N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1989 Apr 1;49(7):1797–1801. [PubMed] [Google Scholar]
  34. Scheurlen W. G., Schwabe G. C., Joos S., Mollenhauer J., Sörensen N., Kühl J. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol. 1998 Jul;16(7):2478–2485. doi: 10.1200/JCO.1998.16.7.2478. [DOI] [PubMed] [Google Scholar]
  35. Schneider S. S., Hiemstra J. L., Zehnbauer B. A., Taillon-Miller P., Le Paslier D. L., Vogelstein B., Brodeur G. M. Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma. Mol Cell Biol. 1992 Dec;12(12):5563–5570. doi: 10.1128/mcb.12.12.5563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schwab M. Amplification of oncogenes in human cancer cells. Bioessays. 1998 Jun;20(6):473–479. doi: 10.1002/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  37. Smiraglia D. J., Frühwald M. C., Costello J. F., McCormick S. P., Dai Z., Peltomäki P., O'Dorisio M. S., Cavenee W. K., Plass C. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. Genomics. 1999 Jun 15;58(3):254–262. doi: 10.1006/geno.1999.5840. [DOI] [PubMed] [Google Scholar]
  38. Squire J. A., Thorner P. S., Weitzman S., Maggi J. D., Dirks P., Doyle J., Hale M., Godbout R. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene. 1995 Apr 6;10(7):1417–1422. [PubMed] [Google Scholar]
  39. Stewart E. A., McKusick K. B., Aggarwal A., Bajorek E., Brady S., Chu A., Fang N., Hadley D., Harris M., Hussain S. An STS-based radiation hybrid map of the human genome. Genome Res. 1997 May;7(5):422–433. doi: 10.1101/gr.7.5.422. [DOI] [PubMed] [Google Scholar]
  40. Thoraval D., Asakawa J., Wimmer K., Kuick R., Lamb B., Richardson B., Ambros P., Glover T., Hanash S. Demethylation of repetitive DNA sequences in neuroblastoma. Genes Chromosomes Cancer. 1996 Dec;17(4):234–244. doi: 10.1002/(SICI)1098-2264(199612)17:4<234::AID-GCC5>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  41. Wasson J. C., Saylors R. L., 3rd, Zeltzer P., Friedman H. S., Bigner S. H., Burger P. C., Bigner D. D., Look A. T., Douglass E. C., Brodeur G. M. Oncogene amplification in pediatric brain tumors. Cancer Res. 1990 May 15;50(10):2987–2990. [PubMed] [Google Scholar]
  42. Wimmer K., Zhu X. X., Lamb B. J., Kuick R., Ambros P. F., Kovar H., Thoraval D., Motyka S., Alberts J. R., Hanash S. M. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene. 1999 Jan 7;18(1):233–238. doi: 10.1038/sj.onc.1202287. [DOI] [PubMed] [Google Scholar]
  43. Yoshikawa H., de la Monte S., Nagai H., Wands J. R., Matsubara K., Fujiyama A. Chromosomal assignment of human genomic NotI restriction fragments in a two-dimensional electrophoresis profile. Genomics. 1996 Jan 1;31(1):28–35. doi: 10.1006/geno.1996.0005. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES